Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-25

Clinical Trial Update: Interferon Alfa in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on Phase 1 and Phase 2 studies evaluating Interferon Alfa in patients with advanced kidney cancer, and notes the trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon Alfa (interferon alfa)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Kidney Cancer | Phase 1, Phase 2 | Status: COMPLETED